Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer

British Journal of Cancer, Published online: 26 October 2020; doi:10.1038/s41416-020-01120-zCirculating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer

Source: British Journal of Cancer - October 26, 2020 Category: Cancer & Oncology Authors: Frances Willenbrock Catrin M. Cox Eileen E. Parkes Charlotte S. Wilhelm-Benartzi Aswin G. Abraham Robert Owens Ahmad Sabbagh Christopher M. Jones Daniel L. I. Hughes Tim Maughan Christopher N. Hurt Eric E. O ’Neill Somnath Mukherjee Source Type: research